Arctic Fox AI
AFX Medical provides AI-powered radiology tools for brain disease treatment, maximizing patient data use.
AFX Medical provides AI-powered radiology tools for brain disease treatment, maximizing patient data use.
Arctic Fox AI, operating under the brand AFX Medical, was founded with the mission to revolutionize brain disease treatment through AI-powered radiology tools. The company's vision is to enhance the precision and speed of cancer diagnosis and treatment, particularly focusing on neuro-oncology. Their core products include automated detection and tracking systems designed to maximize the use of patient data, thereby improving outcomes for conditions like Alzheimer's, dementia, and brain tumors. AFX Medical primarily targets clinicians and healthcare providers who require advanced tools to manage complex brain diseases.
Notable affiliated individuals and investors in Arctic Fox AI include experts in radiology and AI technology, although specific names are not provided. The company has achieved significant milestones by developing tools that address the limitations of human cognition in detecting brain tumors, potentially impacting the care of millions of cancer patients annually. Their innovative approach has positioned them as a critical player in the medical technology space, contributing to more accurate and timely diagnoses and better patient care overall.
Companies similar to Arctic Fox AI include RAD AI, Avalon AI, RapidAI and MedCognetics.
Arctic Fox AI was founded in 2018.
Arctic Fox AI's headquarters is located in Montreal, Quebec, CA.
Arctic Fox AI's most recent funding round was for CA$35k (CAD) in May 2021.
As of May 1, 2021, Arctic Fox AI has disclosed funding of $148.5k (USD). Undisclosed round amounts are excluded.
Arctic Fox AI has 5 employees as of Feb 4, 2024.
MedCognetics
medcognetics.com
